News related to Singulair (Montelukast) and/or conditions it is approved for
ACAAI: Tots with Asthma Benefit from Montelukast (CME/CE)
Source: MedPage Today Allergy & Immunology [2009.11.12]
MIAMI BEACH (MedPage Today) -- Treating asthmatic children as young as 6 months with the leukotriene receptor antagonist montelukast (Singulair) appears effective, according to pooled analyses of two similar randomized clinical trials.
ACAAI: Fluticasone Plus Salmeterol Cuts Exacerbations in Asthma (CME/CE)
Source: MedPage Today Allergy & Immunology [2009.11.12]
MIAMI BEACH (MedPage Today) -- Researchers reported here that pediatric patients with asthma treated with fluticasone propionate plus salmeterol in a fixed-dose combination experienced fewer serious asthma exacerbations and lower costs when compared with the use of inhaled corticosteroids plus montelukast.
|
